Patch testing: Pitfalls and performance

Current Opinion in Allergy and Clinical Immunology

Volumn 6, Issue 5, 2006, Pages 340-344

  Mowad, Christen M ^a  

^a GEISINGER MEDICAL CENTER   (United States)

Author keywords

Allergists; Contact dermatitis; Dermatologists; Diagnosis; Education; Patch testing; Pitfalls

Indexed keywords

ALLERGEN;

CLINICAL PRACTICE; CONTACT DERMATITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; HYPERSENSITIVITY REACTION; PATCH TEST; PATIENT EDUCATION; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SKIN IRRITATION;

ALLERGENS; DERMATITIS, ALLERGIC CONTACT; HUMANS; HYPERSENSITIVITY; PATCH TESTS;

EID: 33748580266     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/01.all.0000244794.03239.8e     Document Type: Review

References (28)

1. Belsito DV. The diagnostic evaluation, treatment and prevention of allergic contact dermatitis in the new millennium. J Allergy Clin Immunol 2000; 105:409-420.
2. Fleming CJ, Burden AD, Forsyth A. Accuracy of questions related to allergic contact dermatitis. Am J Contact Dermatitis 2000; 11:218-221.
3. Rajajopalan R, Anderson RT, Sarma S, et al. An economic evaluation of patch testing in the diagnosis and management of allergic contact dermatitis. Am J Contact Dermatitis 1998; 9:149-154.
4. Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol 2003; 49:1037-1048.
5. Farrell Al, Warshaw EM, Zhao Y, Nelson D. Prevalence and methodology of patch testing by allergists in the United States: results of a cross-sectional survey. Am J Contact Dermatitis 2002; 13:157-163.
6. Fonacier L, Charlesworth EM, Muk WY, Babna SL. American College of Allergy, Asthma and Immunology patch testing and allergic dermatologic disease survey: use of patch testing and effect of education on confidence, attitude and usage. Am J Contact Dermatitis 2002; 13:164-169.
7. James WD, Rosenthal LE, Brancaccio RR, et al. American Academy of Dermatology patch testing survey; use and effectiveness of the procedure. J Am Acad Dermatol 1992; 26:991-994.
8. Warshaw EM, Nelson D. Prevalence of patch testing and methodology of dermatologists in the United States: results of a cross-sectional survey. Am J Contact Dermatitis 2002; 13:53-58.
9. Warshaw EM, Moore JB, Nelson D. Patch testing practices of American Contact Dermatitis Society members: a cross-sectional survey. Am J Contact Dermatitis 2003; 14:5-11.
10. Rietschel RL, Adams RM, Maibach HI, et al. The case for patch test readings beyond day 2. J Am Acad Dermatol 1988; 18:42-45.
11. Uter WJC, Geier J, Schnuch A. Good clinical practice in patch testing: readings beyond day 2 are necessary: a confirmatory analysis. Am J Contact Dermatitis 1996; 7:231-237.
12. Larkin A, Rietschel RL. The utility of patch tests using larger screening series of allergens. Am J Contact Dermatitis 1998; 9:142-145.
13. Saripalli YV, Achen F, Belsito DV. The detection of clinically relevant contact allergens using a standard screening tray of twenty-three allergens. J Am Acad Dermatol 2003; 49:65-69.
14. Cohen DE, Brancaccio R, Andersen D, Belsito DV. Utility of a standard allergen series alone in the evaluation of allergic contact dermatitis: a retrospective study of 732 patients. J Am Acad Dermatol 1997; 36:914-918.
15. Hjorth N. The development of the patch testing procedure and working for consistency. J Am Acad Dermatol 1989; 21:855-857.
16. Goulden V, Wilkinson SM. Evaluation of a contact allergen clinic. Clinical Exp Dermatol 2000; 25:67-70.
17. Condie MW, Adams RM. Influence of oral prednisone on patch test reactions to Rhus antigen. Arch Dermatol 1973; 107:540-543.
18. Sukanto H, Nater JP, Bleumink E. Influence of topically applied corticosteroids on patch test reactions. Contact Dermatitis 1981; 7:180-185.
19. Katz BE, Fisher AA. Bacitracin: a unique topical antibiotic sensitizer. J Am Acad Dermatol 1987; 17:1016-1024.
20. Freeman S. Corticosteroid allergy. Contact Dermatitis 1995; 33:240-242.
21. Pratt M, Taraska V. Disperse blue dyes 106 and 124 are common cause of textile dermatitis and should serve as screening allergens for this condition. Am J Contact Dermatitis 2000; 11:30-41.
22. DeGroot AC. Patch testing; concentration and vehicles for 3700 allergens. 2nd ed. Amsterdam: Elsevier; 1994.
23. Pratt MD, Belsito DV, DeLeo VA, et al. North American Contact Dermatitis Group patch test results; 2001-2002 study period. Dermatitis 2004; 15:176-183.
24. Paul MA, Fleischer AB, Sherertz EF. Patients' benefit from contact dermatitis evaluation: results of a follow-up study. Am J Contact Dermatitis 1995; 6:63-66.
25. Lewis FM, Cork MJ, McDonagh AJG, Gawkrodger DDJ. An audit of the value of patch testing: the patients' perspective. Contact Dermatitis 1993; 30:214-216.
26. Edman B. The usefulness of detailed information to patients with contact allergy. Contact Dermatitis 1988; 19:43-47.
27. Code of Federal Regulations, Title 21, Vol. 7, Section 700.3(d).
28. Scheiman P. The foul side of fragrance-free products: what every clinician should know about managing patients with fragrance allergy. J Am Acad Dermatol 1999; 41:1020-1024.